|
US2021115454A1
|
|
Compositions and methods of biosynthesizing carotenoids and their derivatives
|
|
WO2021076638A1
|
|
Biosynthesis of eriodictyol
|
|
WO2021067974A1
|
|
Biosynthesis of alpha-ionone and beta-ionone
|
|
WO2020223418A2
|
|
Biosynthesis of vanillin from isoeugenol
|
|
WO2020223417A1
|
|
Biosynthesis of vanillin from isoeugenol
|
|
WO2020205685A1
|
|
Biosynthetic production of udp-rhamnose
|
|
WO2020191385A1
|
|
Biosynthetic production of gamma- and delta-lactones using cytochrome p450 enzymes having subterminal hydroxylase activity
|
|
WO2020123877A1
|
|
Biosynthetic production of variant steviol glycosides
|
|
WO2020077367A1
|
|
Biosynthesis of homoeriodictyol
|
|
WO2020061385A1
|
|
Controllable protein degradation via engineering degradation tag variants in corynebacterium host cells
|
|
WO2020018729A1
|
|
Biosynthetic production of gamma-lactones
|
|
WO2019213069A1
|
|
Recombinant organisms and methods for producing glycomolecules with low sulfation
|
|
EP3788164A1
|
|
Recombinant organisms and methods for producing glycomolecules with high glycan occupancy
|
|
CN111868252A
|
|
Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N
|
|
US2019078102A1
|
|
Biosynthetic production of steviol glycosides and processes therefore
|
|
CN111201314A
|
|
Plasmid addiction systems driving expression of desired genes
|
|
US2019024097A1
|
|
Plasmid addiction system to drive desired gene expression
|
|
US2019048374A1
|
|
Biosynthesis of eriodictyol from engineered microbes
|
|
CN110809408A
|
|
Hydrolysis of steviol glycosides by β -glucosidase
|
|
US2018251569A1
|
|
Expression of modified glycoproteins and glycopeptides
|
